<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is a <z:hpo ids='HP_0011010'>chronic</z:hpo> relapsing multisystemic <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disorder</z:e> characterized by four major symptoms (oral aphthous <z:mpath ids='MPATH_579'>ulcers</z:mpath>, <z:hpo ids='HP_0003249'>genital ulcers</z:hpo>, <z:mp ids='MP_0001212'>skin lesions</z:mp>, and ocular lesions) and occasionally by five minor symptoms (<z:hpo ids='HP_0001369'>arthritis</z:hpo>, <z:mp ids='MP_0003300'>gastrointestinal ulcers</z:mp>, <z:hpo ids='HP_0000031'>epididymitis</z:hpo>, vascular lesions, and central <z:mp ids='MP_0008912'>nervous</z:mp> system symptoms) </plain></SENT>
<SENT sid="1" pm="."><plain>Although the etiology of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is still unknown, there have been recent advances in immunopathogenic studies, genome-wide association studies, animal models, diagnostic markers, and new biological agents </plain></SENT>
<SENT sid="2" pm="."><plain>These advances have improved the clinical understanding of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease and have enabled us to develop new treatment strategies for this intractable disease, which remains one of the leading causes of <z:hpo ids='HP_0000618'>blindness</z:hpo> </plain></SENT>
</text></document>